Summary of the Conference Call for 华测检测 (Huace Testing) Company Overview - **Company**: 华测检测 (Huace Testing) - **Industry**: Testing, Inspection, and Certification (TIC) Key Points 2026 Performance Guidance - The company aims for a growth of 15% or more in 2026, with approximately 5% of this growth expected from overseas acquisitions completed in Q4 2025, including SafetySA, M-Cert, and OpenView [2][20] Medical and Pharmaceutical Segment - The medical segment is anticipated to recover in 2025 and accelerate growth in 2026, benefiting from the availability of experimental monkeys and improved CRO order intake, leading to a significant reduction in losses and an increase in gross margin [2][5] - The introduction of a chief scientist in the Kunshan preclinical evaluation business is expected to help tackle major R&D challenges and attract projects [5] - The new Kunshan medical device laboratory is projected to be a core growth point, with operations starting in January 2026 [6][23] Semiconductor Testing Business - The semiconductor testing segment is expected to achieve breakeven in 2026, focusing on automotive-grade chip domestic substitution and computing chips [2][7] - The company has invested in capacity release and team optimization, with a focus on high-margin segments [7] Internationalization Strategy - The company plans to increase the proportion of overseas business to over 20% within 3-5 years, with a focus on Southeast Asia, Europe, Africa, and the Middle East [4][5] - Recent acquisitions in Greece (M-Cert) and Vietnam (OpenView) are expected to significantly contribute to overseas business growth in 2026 [4][5] Emerging Markets and New Business Areas - The smart driving sector has orders booked until mid-2026, with new business areas such as low-altitude economy, robotics, and carbon emission certification expected to drive growth in 2026 [2][5] Capital Expenditure and Dividends - The capital expenditure budget for 2026 is set at around 7% of revenue, with a stable dividend policy likely to maintain mid-term dividends [3][10][26] AI and Digitalization - The company has implemented AI technology in 37 scenarios, significantly improving operational efficiency, with some applications reducing manual review workloads by up to 80% [21] Market Conditions and Pricing Pressure - The automotive sector is facing price competition, but the company is leveraging operational efficiency to mitigate this [9][25] - The medical segment is experiencing a recovery in pricing due to a shortage of experimental monkeys and reduced competition [9] Future Growth and Strategic Focus - The company aims to maintain sustainable growth and quality, with a focus on long-term strategic investments even if they impact short-term profits [27] - The company is committed to becoming a top ten global TIC provider, emphasizing talent development and integration of diverse backgrounds [27] Financial Contributions from Acquisitions - The acquisitions of M-Cert, OpenView, and CFA S.A. are expected to contribute significantly to revenue and profit in 2026, with M-Cert and OpenView projected to grow over 20% [21][22] Environmental Business Outlook - The environmental segment is expected to see stable growth, with a focus on new projects and cost control measures [11][12] Conclusion - Overall, the company is positioned for significant growth in 2026, driven by strategic acquisitions, recovery in key segments, and a strong focus on operational efficiency and international expansion [2][20][27]

Overall Situation - The Zhuhai Doumen District Market Supervision Administration conducted routine food safety sampling inspections, with a total of 58 batches sampled, primarily consisting of edible agricultural products and catering foods [2]. - The sampling and inspection were carried out in accordance with national regulations and standards for food safety [2]. Sampling Analysis - All 58 batches of samples tested were found to be compliant with safety standards [3]. Special Notice - Consumers are encouraged to report any non-compliant food products by calling the 12345 hotline [4]. - Individuals or organizations disputing the published information can apply for a review within 30 days from the date of publication [4].

Group 1 - The core viewpoint of the article highlights that the company, Lianjian Technology, possesses various food testing qualifications, including CMA, CNAS, and CATL, indicating its strong capabilities in food safety testing [2] - The company's business capabilities cover all 33 categories of products outlined in the national food safety supervision implementation rules, demonstrating comprehensive service offerings in the food testing sector [2] - Lianjian Technology also has testing capabilities for pet food, feed, and food contact materials, expanding its market reach and service diversity [2] Group 2 - The testing projects offered by the company include food additives, pesticide residues, veterinary drug residues, heavy metals, mycotoxins, contaminants, illegal additives, microorganisms, routine physical and chemical indicators of food, and food nutrition labels, showcasing a wide range of expertise [2]

Summary of Huace Testing Conference Call Company Overview - **Company**: Huace Testing - **Industry**: Testing, Inspection, and Certification (TIC) Key Financial Performance - **Revenue**: In the first three quarters of 2025, revenue reached 6.6 billion CNY, a year-on-year increase of 9.26% [2][3] - **Net Profit**: Net profit attributable to shareholders was 1.812 billion CNY, with a net profit margin of 17.28%, up by 0.29 percentage points year-on-year [2][3] - **Operating Cash Flow**: Operating cash flow net amount was 596 million CNY, a significant increase of 11% year-on-year [2][3] - **Q3 Performance**: In Q3 2025, revenue was 1.742 billion CNY, up 8.53% year-on-year, with net profit of 345 million CNY, an increase of 11.24% [3] Business Segment Performance - **Life Sciences**: Benefited from improved efficiency and precise market positioning, with notable performance in food testing [2][5] - **Environmental Testing**: Focused on traditional markets while expanding into emerging fields [2][5] - **Consumer Testing**: Significant progress in new energy vehicles and aerospace sectors [2][5] - **Pharmaceutical and Medical Services**: Strategic investments led to rapid gross margin improvement; CRO business expanded through acquisitions [2][5][7] - **International Strategy**: Accelerated internationalization through acquisitions, such as Safety SA in South Africa, enhancing global capabilities [2][11] Digital Transformation and AI Integration - **Digital Tools**: Implementation of ERP systems and various digital tools like BI and RPA to enhance operational efficiency [2][16] - **AI Applications**: Ongoing exploration of AI applications across multiple fields to improve efficiency and reduce labor needs [2][16] Future Outlook - **Growth Projections**: Anticipated acceleration in growth for Q4 2025, driven by new acquisitions contributing to overall performance [4][22] - **Long-term Strategy**: The pharmaceutical and medical services segment is expected to recover to 10% of the group's revenue share, with significant potential for growth in emerging fields [10][9] International Expansion - **Focus Areas**: Future international expansion will target consumer goods, shipping, and food sectors, with a preference for acquisitions related to product certification and digital certification [14][15] - **Market Opportunities**: South Africa and Southeast Asia identified as key regions for growth, with plans to leverage local resources and regulatory frameworks [12][15] Competitive Advantages - **Global Positioning**: Huace Testing's acquisitions enhance its competitive edge in various regions, allowing for localized testing and certification services [20][21] Conclusion - **Overall Sentiment**: The company maintains an optimistic outlook for future growth, supported by strategic acquisitions and a focus on digital transformation and international expansion [6][22]

Core Viewpoint - The company, Lianjian Technology (301115.SZ), has confirmed that it is not currently involved in nuclear radiation testing in the food inspection sector [1] Group 1: Company Capabilities - The company possesses various food testing qualifications including CMA (national and provincial levels), CNAS, and CATL [1] - Its business capabilities cover all 33 major product categories outlined in the national food safety supervision implementation guidelines [1] - The company has testing capabilities for pet food, feed, and food contact materials [1] Group 2: Testing Scope - The testing projects include food additives, pesticide residues, veterinary drug residues, heavy metals, mycotoxins, contaminants, illegal additives, microorganisms, routine physical and chemical indicators of food, and food nutrition labels [1]

Group 1 - The company, Lianjian Technology (301115.SZ), has stated that it is currently not involved in nuclear radiation testing in the food detection sector [1] - The company possesses various food testing qualifications, including CMA (national and provincial levels), CNAS, and CATL, covering all 33 major product categories outlined in national food safety supervision implementation guidelines [1] - The company's testing capabilities include pet food testing, feed testing, and testing of food contact materials, with projects covering food additives, pesticide residues, veterinary drug residues, heavy metals, mycotoxins, pollutants, illegal additives, microorganisms, routine physical and chemical indicators of food, and food nutrition labels [1]

Group 1 - The recent strategic cooperation between Huace Testing (300012) and Hong Kong Polytechnic University focuses on the full industry chain demand for functional foods [1] - The collaboration emphasizes three core areas: food testing, technological innovation, and creative services [1] - The initiative aims to establish a deep integration platform for industry, academia, and research [1]

Core Viewpoint - The new 2025 version of the "General Standard for Nutrition Labeling of Prepackaged Foods" will include "sugar" as a mandatory labeling item, leading to increased demand for analysis and testing technologies, thereby driving upgrades in analytical testing capabilities [1][2]. Group 1: Expansion of Testing Items and Scope - The new standard expands the mandatory labeling content from "1+4" to "1+6," adding saturated fat and sugar, and requires the labeling of trans fatty acids when hydrogenated oils are used [4]. - The new standard specifies that the sugar content refers to the sum of fructose, glucose, sucrose, maltose, and lactose, necessitating quantitative testing for foods that previously did not require sugar content detection [4]. - The allowable error range for sugar is strictly defined as "measured value ≤ 120% of the labeled value," which raises the accuracy and repeatability requirements for testing methods [4]. Group 2: Upgrading Testing Methodologies and Technical Adaptation Pressure - The new standard necessitates the adoption of updated testing methods for sugars and fatty acids, with the introduction of GB 5009.8-2023, which replaces previous standards and will be implemented on March 6, 2024 [6]. - The updated methods include four testing techniques: high-performance liquid chromatography, ion chromatography, acid hydrolysis-Rhein method, and Rhein method, each suitable for different food matrices [6][7][8]. - The revision of GB 28050 not only standardizes food labeling information but also serves as a comprehensive test of the analytical testing industry's technical capabilities, requiring timely upgrades of software and hardware by testing institutions during the two-year transition period [9].

Summary of Key Points Core Viewpoint - The Wuxi New District Market Supervision Administration has conducted food safety inspections in 2025, revealing that out of 936 food samples tested, 900 passed while 36 failed, indicating a compliance rate of approximately 96.2% [4][5]. Group 1: Inspection Results - A total of 936 food samples were inspected in Wuxi New District [4][5]. - Out of these, 900 samples were found to be compliant, resulting in a compliance rate of 96.2% [4][5]. - 36 samples were deemed non-compliant, highlighting potential food safety issues in the market [4][5]. Group 2: Consumer Advisory - The Market Supervision Administration encourages consumers to report any food safety violations by calling the hotline 12315 [4][5]. - This initiative aims to enhance consumer awareness and participation in food safety monitoring [4][5]. Group 3: Non-compliant Food Items - Specific non-compliant food items include: - A beverage containing sorbic acid at 0.129g/kg, exceeding the allowable limit [5]. - Ginger samples with pesticide residues (acetamiprid) at 0.76mg/kg, surpassing the permissible level [5]. - Various other food items with pesticide residues exceeding regulatory limits [5][6].

Summary of Huace Testing Conference Call Company Overview - **Company**: Huace Testing - **Recent Acquisition**: Acquired South African company Fifty to enhance overseas expansion capabilities, particularly in food safety [2][4] Key Points and Arguments Acquisition Details - The acquisition of Fifty is aimed at strengthening Huace Testing's international presence and addressing weaknesses in training services [2][4] - The acquisition will be funded through cash, with sufficient cash flow to support the transaction without the need for stock issuance [2][6] Financial Performance - Overall revenue growth target for the year remains at 10%, despite seasonal uncertainties in quarterly performance [2][7] - Last year's Q2 revenue was approximately 1.6 billion, with the Sanpu business contributing about 100 million, accounting for roughly 6% [2][8] - The food testing segment showed robust performance with nearly 10% growth last year and 15% growth in Q1 of this year, expected to maintain around 10% growth for the year [2][10] - Environmental testing projects exceeded expectations in Q1 but are expected to face pressure in Q2 due to government budget tightening [2][9] - The pharmaceutical and medical segment incurred losses last year, with a goal to reduce losses this year, although the pressure to turn profitable remains significant [2][11] Business Segment Insights - The Beisbo business is gradually improving as equipment is being installed, while the Yima business is facing challenges in the German market but performing well in the US and Mexico [2][12] - The domestic automotive market remains stable, with Huace Testing achieving high single-digit growth and improved gross margins through enhanced internal lab efficiency [2][13][18] - The CRO business in drug testing is on an upward trend, with the CMC sector doubling last year and maintaining stability this year [2][14][15] Market and Industry Trends - The testing industry is experiencing intensified price competition due to increased market saturation, impacting profitability [2][17] - Huace Testing is exploring opportunities in the African market due to its recent growth, with potential future expansions into other regions based on market conditions [2][5] Capital Expenditure and Personnel Management - Capital expenditure has been reduced from 10% to 7% of revenue, reflecting a shift in investment strategy due to market conditions [2][21] - Personnel management will continue to align with revenue growth, with an emphasis on improving employee efficiency [2][22] Future Outlook - The company is optimistic about achieving its annual performance targets, although quarterly performance may vary based on seasonal factors [2][28] - The acquisition of the South African company is expected to be consolidated in the second half of 2025, with other potential acquisitions also in progress [2][29] Additional Important Insights - The company is investing in smart driving technologies and electric motor control, aligning with industry trends [2][19] - The development of standards in smart driving technology is still in its early stages, with ongoing collaborations with automotive manufacturers [2][20] - The trade assurance segment has shown over 15% growth in Q1, largely due to acquisitions made last year [2][16]